MedPath

3D Maternal Fetal Attachment and Smoking

Not Applicable
Conditions
Maternal-Fetal Relations
Maternal Behavior
Registration Number
NCT04541121
Lead Sponsor
Creighton University
Brief Summary

To determine whether 3D models of fetus' face created from 3D ultrasound will increase maternal attachment and aid in smoking cessation. Half of participants will receive 3D model and half will receive a picture of 3D ultrasound of their baby

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
96
Inclusion Criteria
  • Age - Female 19-45 years of age
  • Fluent in English
  • Currently smoking cigarettes
  • Currently pregnant (between 21- and 36-weeks' gestation)
  • Have normal 20-week ultrasound
Exclusion Criteria
  • Having received more than 3 ultrasounds prior to study
  • Medical need for additional ultrasounds
  • Multiple fetuses
  • > 31 weeks gestation
  • Does not smoke cigarettes
  • Is not fluent in English

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Maternal Antenatal Attachment Scale (MAAS)5 minutes

The MAAS is a 19 item questionnaire measuring maternal-fetal attachment. Each item has five answer choices scored from 1 low attachment to 5 high attachment such that the total score ranges from 19 to 95. The measure also includes two subscales: (1) Quality of Attachment has 10 items with a range of 10-50 and measures the quality of the mother's attachment to her fetus. (2) Time measures the time spent in attachment mode (or intensity of preoccupation) and consists of 8 items for a range of 8 to 40. (for clarity one item included in the total score is not included in either subscale.)

Salivary cotinine5 minutes

Cotinine is a stable nicotine metabolite produced by the liver. This is to test amount mother has smoked.

The Timeline Follow Back (TLFB):10 minutes

This semi-structured interview utilizes a calendar to aid in participants' recall of smoking throughout pregnancy. The TLFB method is the preferred approach to measure substance use and has shown reliability when used for pregnant women in previous studies

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Creighton University

🇺🇸

Omaha, Nebraska, United States

Creighton University
🇺🇸Omaha, Nebraska, United States
Nicole Santek
Contact
402-280-2322
nicolesantek@creighton.edu
Amy Badura Brack, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.